Reposal
From Wikipedia, the free encyclopedia
|
Reposal
|
|
| Systematic (IUPAC) name | |
| 5-(3-bicyclo[3.2.1]oct-3-enyl)-5-ethyl-1,3-diazinane-2,4,6-trione | |
| Identifiers | |
| CAS number | |
| ATC code | N05 |
| PubChem | |
| Chemical data | |
| Formula | C14H18N2O3 |
| Mol. mass | 262.304 g/mol |
| Synonyms | Reposal, 5-Ethyl-5-(bicyclo(3.2.1)octenyl)barbituric acid |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Reposal is a barbiturate derivative invented in the 1960s in Denmark. It has sedative, hypnotic and anticonvulsant properties, and was used primarily for the treatment of insomnia.[1][2]
[edit] References
- ^ Kessing SV, Tarding F, Thomsen AC. Reposal, A New Hypnotic. (Danish) Ugeskrift for Læger. 1963 Dec 6;125:1735-1741.
- ^ Nielsen P, Tarding F. The metabolic fate of 5-(bicyclo-3,2,1,-oct-2-en-2-yl)-5-ethyl barbituric acid, (Reposal). Acta Pharmacologica et Toxicologica (Copenhagen). 1968;26(6):521-30.
|
|||||

